SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-003710
Filing Date
2017-03-08
Accepted
2017-03-08 16:40:22
Documents
8
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K anab-10k_20161231.htm 10-K 3485515
2 EX-21.1 anab-ex211_109.htm EX-21.1 2416
3 EX-31.1 anab-ex311_9.htm EX-31.1 7945
4 EX-31.2 anab-ex312_8.htm EX-31.2 7924
5 EX-32.1 anab-ex321_7.htm EX-32.1 6566
6 EX-32.2 anab-ex322_6.htm EX-32.2 6556
7 GRAPHIC g2017030723154978827529.jpg GRAPHIC 47463
8 GRAPHIC g2017030723154892427528.jpg GRAPHIC 33100
  Complete submission text file 0001564590-17-003710.txt   3629262
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37985 | Film No.: 17675576
SIC: 2834 Pharmaceutical Preparations